These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 158641)

  • 1. The role of biogenic amines in amygdalar kindling. I. Local amygdalar afterdischarge.
    Wilkison DM; Halpern LM
    J Pharmacol Exp Ther; 1979 Oct; 211(1):151-8. PubMed ID: 158641
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of reserpine on the development of local afterdischarge during amygdaloid kindling in the rat.
    Wilkison DM; Halpern LM
    Proc West Pharmacol Soc; 1977; 20():283-6. PubMed ID: 896837
    [No Abstract]   [Full Text] [Related]  

  • 3. Reserpine-induced alterations in brain amines and their relationship to changes in the incidence of minimal electroshock seizures in mice.
    Azzaro AJ; Wenger GR; Craig CR; Stitzel RE
    J Pharmacol Exp Ther; 1972 Mar; 180(3):558-68. PubMed ID: 4258979
    [No Abstract]   [Full Text] [Related]  

  • 4. Effects of reserpine, alpha-methyl-p-tyrosine, p-chlorophenylalanine and 5,7-dihydroxytryptamine on the hippocampal kindling effect in rats.
    Araki H; Aihara H; Watanabe S; Yamamoto T; Ueki S
    Jpn J Pharmacol; 1983 Dec; 33(6):1177-82. PubMed ID: 6230476
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biogenic amines and narcotic effects. I. Modification of morphine-induced analgesia and motor activity after alteration of cerebral amine levels.
    Buxbaum DM; Yarbrough GG; Carter ME
    J Pharmacol Exp Ther; 1973 May; 185(2):317-27. PubMed ID: 4267383
    [No Abstract]   [Full Text] [Related]  

  • 6. Neurochemical changes following the administration of depleters of biogenic monoamines.
    Lane JD; Smith JE; Shea PA; McBride WJ
    Life Sci; 1976 Dec; 19(11):1663-7. PubMed ID: 12434
    [No Abstract]   [Full Text] [Related]  

  • 7. [Aminergic neuromodulation and the antinociceptive action of morphine and T.R.H].
    Alamo C; Serrano MI; Aragón A; Cuenca E
    Arch Farmacol Toxicol; 1979 Dec; 5(3):172-6. PubMed ID: 161860
    [No Abstract]   [Full Text] [Related]  

  • 8. The role of biogenic amines in the reserpine-induced alteration of minimal electroshock seizure thresholds in the mouse.
    Wenger GR; Stitzel RE; Craig CR
    Neuropharmacology; 1973 Jul; 12(7):693-703. PubMed ID: 4147164
    [No Abstract]   [Full Text] [Related]  

  • 9. Identification of nonserotonergic [3H]ketanserin binding sites associated with nerve terminals in rat brain and with platelets; relation with release of biogenic amine metabolites induced by ketanserin- and tetrabenazine-like drugs.
    Leysen JE; Eens A; Gommeren W; van Gompel P; Wynants J; Janssen PA
    J Pharmacol Exp Ther; 1988 Jan; 244(1):310-21. PubMed ID: 3336007
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Brain monoamines and the high pressure neurological syndrome.
    Koblin DD; Little HJ; Green AR; Daniels S; Smith EB; Paton WD
    Neuropharmacology; 1980 Nov; 19(11):1031-8. PubMed ID: 6449674
    [No Abstract]   [Full Text] [Related]  

  • 11. Supraspinal monoaminergic involvement in the blockade of recurrent inhibition of the monosynaptic reflex.
    Sinclair JG; Sastry BS
    Neuropharmacology; 1974 Aug; 13(8):741-7. PubMed ID: 4280526
    [No Abstract]   [Full Text] [Related]  

  • 12. Pilocarpine-induced purposeless chewing behaviour in rats is dependent on intact central stores of 5-HT.
    Stewart B; Rose S; Jenner P; Marsden CD
    Eur J Pharmacol; 1987 Oct; 142(1):173-6. PubMed ID: 2961579
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Indolealkylamine nerve terminals in cerebral ventricles: identification by electron microscopy and fluorescence histochemistry.
    Richards JG; Lorez HP; Tranzer JP
    Brain Res; 1973 Jul; 57(2):277-88. PubMed ID: 4352871
    [No Abstract]   [Full Text] [Related]  

  • 14. The relationship between magnitude of electroshock stimulation and the effects of digitoxigenin, pentylenetetrazol and brain monoamine reduction on electroshock convulsive thresholds.
    Buterbaugh GG; London ED
    Neuropharmacology; 1977 Sep; 16(9):617-23. PubMed ID: 144247
    [No Abstract]   [Full Text] [Related]  

  • 15. Aminergic involvement in the control of luteinizing hormone secretion in the domestic fowl.
    Buonomo FC; Rabii J; Scanes CG
    Gen Comp Endocrinol; 1981 Oct; 45(2):162-6. PubMed ID: 6269957
    [No Abstract]   [Full Text] [Related]  

  • 16. Functions of the hypothalamus and amygdala in regulation of growth hormone secretion.
    Martin JB
    Trans Am Neurol Assoc; 1973; 98():229-32. PubMed ID: 4274162
    [No Abstract]   [Full Text] [Related]  

  • 17. Selective facilitation of kindled seizures from the amygdala after hippocampal lesions induced by perforant path stimulation.
    Mazarati AM; Wasterlain CG
    Neurosci Lett; 1997 Mar; 224(3):165-8. PubMed ID: 9131662
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biogenic amines and affective disorders. A critical analysis.
    Luchins D
    Int Pharmacopsychiatry; 1976; 11(3):135-49. PubMed ID: 136425
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proceedings: Amine depletion as an experimental approach to the aminergic hypothesis.
    Mendels J
    Psychopharmacol Bull; 1974 Oct; 10(4):54-6. PubMed ID: 4279415
    [No Abstract]   [Full Text] [Related]  

  • 20. Unilateral low-frequency stimulation of central piriform cortex inhibits amygdaloid-kindled seizures in Sprague-Dawley rats.
    Zhu-Ge ZB; Zhu YY; Wu DC; Wang S; Liu LY; Hu WW; Chen Z
    Neuroscience; 2007 May; 146(3):901-6. PubMed ID: 17412517
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.